Shanghai Dermatology Hospital Report issue

Academic/Hospital Phase 2 Phase 4
Founded: Shanghai China

Organization Overview

First Clinical Trial
2015
NCT04202068
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Shanghai Dermatology Hospital

Active Ingredients

Drugs in Phase 4 Trials (2)

ceftriaxone (rocephin) (1 trial)

sulbactam (unasyn) (1 trial)

Drugs in Phase 2 Trials (2)

hs-10374 (1 trial)

jueyin (1 trial)

Drugs in Other Trials (2)

aminolevulinic acid (levulan) (1 trial)

isotretinoin (Accutane) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Gonorrhea (Phase 4)

Psoriasis (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 6